Table 1.
Characteristics of curcumin-treated patients.
Patient | Sex | Age (years) | Subtype | CLSS | Hematuria | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Baseline | 4 weeks | 3 months | 6 months | Baseline | 4 weeks | 3 months | 6 months | ||||
1 | M | 36 | CGTP | 10 | 7 | 5 | 6 | Gross | Micro | Micro | Micro |
2 | M | 58 | CGIT | 10 | 8 | 6 | 6 | Gross | Gross | − | − |
3 | M | 43 | CGTP | 9 | 7 | 5 | 5 | Micro | Micro | Micro | Micro |
4 | F | 64 | CGIT | 10 | 10 | 10 | 10 | Micro | Micro | Micro | Micro |
5 | M | 56 | CGTP | 13 | 9 | 7 | 6 | − | − | − | − |
6 | F | 30 | CGTP | 13 | 9 | 7 | 7 | Micro | Micro | Micro | Micro |
7 | F | 48 | CGTP | 10 | 7 | 6 | 7 | Micro | Micro | Micro | Micro |
8 | M | 23 | CGIT | 12 | 9 | 7 | 7 | Micro | Micro | − | − |
9 | M | 47 | CGIT | 10 | 11 | 10 | 10 | Micro | Micro | Micro | Micro |
10 | F | 42 | CGTP | 10 | 7 | 5 | 6 | − | − | − | − |
11 | M | 72 | CGTP | 10 | 10 | 10 | ND | Micro | Micro | Micro | ND |
12 | F | 18 | CGTP | 9 | 7 | 6 | ND | − | − | − | ND |
13 | M | 52 | CGIT | 9 | 9 | 9 | 9 | Gross | Gross | Micro | Micro |
14 | M | 32 | CGTP | 9 | 6 | 6 | 6 | Gross | Micro | Micro | − |
F: female; M: male; CGTP: typical CG; CGIT: intestinal CG; CLSS: core lower urinary tract symptom score; Micro: microscopic hematuria; Gross: gross hematuria; −: negative hematuria; ND: not determined due to loss to follow-up.